Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Latest News about Unassigned
 
< Previous 1 2 Next >
Three Factors Why Bristol-Myers Is Worth $35
September 10, 2012
about AZN , BMY , GSK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Bristol-Myers Books $1.8 Billion Loss On Discontinuing Development Of Hep-C Drug
August 27, 2012
about ABT , BMY , GSK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
ALS Community Gains Hope Amid Neuralstem’s Surprising Success
August 27, 2012
about CUR , GSK , PFE , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
Abbott’s Next-Generation Stent To Enter Europe After CE Approval
August 21, 2012
about ABT , BSX , GSK , and 2 more.
category Pharmaceuticals , Unassigned , Medical Devices & Supplies
from Trefis
ChromaDex Announces Record Q2 Revenue and Conference Date for September 20
August 14, 2012
about BMY , CDXC , GSK , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
Coverage Launch: $47 Trefis Price Estimate for Roche Holdings
August 13, 2012
about ABT , JNJ , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Abbott Plans New Manufacturing Facility To Expand Indian Nutritional Business
August 13, 2012
about ABT , JNJ , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Bristol-Myers’ $35 Fair Value: Amylin Acquisition Helps Target Diabetes Market
August 10, 2012
about AZN , BMY , GSK , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
A Look At Two Undervalued Small-Cap Health Care Stocks
August 09, 2012
about CPSI , JNJ , NVS , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
Abbott Benefits From Humira’s Additional Treatment Approvals In Europe
August 02, 2012
about ABT , JNJ , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Emergent Key Catalysts To Drive Upside
August 02, 2012
about EMGE , GSK , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Merck Fares Well Despite Currency Impact
August 01, 2012
about ABT , JNJ , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Pfizer’s Earnings Hold Up On International Growth Despite Lipitor Patent Expiry
August 01, 2012
about ABT , JNJ , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Merck’s HIV Franchise Gains Momentum With Two Deals And Trial Plans
July 31, 2012
about ABT , JNJ , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Pfizer Update: EU Panel Recommends Oncology Drug Xalkori
July 31, 2012
about ABT , JNJ , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Pfizer Q2 Earnings Preview: A Tough Quarter On Deck
July 30, 2012
about ABT , JNJ , MRK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Emergent’s Undervalued Business Model To Drive Volumes
July 27, 2012
about EMGE , GSK , MRK , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
Pfizer Defends $25 Fair Value With Lyrica Patent Lawsuit Win
July 26, 2012
about ABT , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Bristol-Myers’ Q2 Earnings Jolted By Patent Cliff But Outlook Is Stable
July 26, 2012
about AZN , BMY , GSK , and 4 more.
category Pharmaceuticals , Unassigned
from Trefis
Merck’s Q2 Earnings Preview: What We Are Watching
July 26, 2012
about ABT , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Bristol-Myers’ Second Quarter Earnings Will Fight Patent Cliff Effects
July 24, 2012
about ABT , AZN , BMY , and 3 more.
category Pharmaceuticals , Unassigned
from Trefis
Merck’s Stock Gets A Boost From Osteoporosis Drug Trials
July 18, 2012
about ABT , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Abbott Could Feel Impact Of Studies Showing Overuse Of Drug-Eluting Stents
July 16, 2012
about ABT , BSX , GSK , and 2 more.
category Pharmaceuticals , Unassigned , Medical Devices & Supplies
from Trefis
Pfizer’s Acquisitions Don’t Guarantee Shareholder Value Creation
July 13, 2012
about ABT , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Abbott Labs Eyes Russian Market With R&D Deal
July 12, 2012
about GSK , JNJ , MRK , and 1 more.
category Pharmaceuticals , Unassigned
from Trefis
Pfizer Forced To Drop Health Claims For Centrum Line of Products
July 11, 2012
about ABT , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
ChromaDex Sales Could Soar From Weight Loss Supplement
July 11, 2012
about ABT , CDXC , GSK , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Pfizer Stock Worth $25 Despite Lawsuits & Lipitor Patent Expiry
July 10, 2012
about ABT , GSK , JNJ , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
ChromaDex (CDXC) Gets the OK On SuperCeutical That Packs the Wallop of 300 Pounds of Blueberries
July 09, 2012
about BIIB , BMTI , CDXC , and 2 more.
category Pharmaceuticals , Unassigned
from Trefis
Medtronic New Coverage: $41 Price Estimate
July 06, 2012
about BSX , GSK , JNJ , and 1 more.
category Pharmaceuticals , Unassigned , Medical Devices & Supplies
from Trefis
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here